Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -32.89% lower on its value in year-to-date trading and has touched a low of $5.26 and a high of $48.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $6.65 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $6.59, the stock is -10.33% and -36.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing -0.90% at the moment leaves the stock -34.72% off its SMA200. DNA registered -84.89% loss for a year compared to 6-month gain of -18.34%. The firm has a 50-day simple moving average (SMA 50) of $10.3308 and a 200-day simple moving average (SMA200) of $10.0954.
The stock witnessed a -27.66% loss in the last 1 month and extending the period to 3 months gives it a -30.34%, and is -8.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.97% over the week and 8.84% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 834 employees, a market worth around $382.44M and $227.04M in sales. Profit margin for the company is -240.94%. Distance from 52-week low is 25.29% and -86.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.37%).
The EPS is expected to grow by 49.93% this year
228.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 85.49% of the company’s shares. The shares outstanding are 42.70M, and float is at 36.98M with Short Float at 26.98%. Institutions hold 79.85% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 6.9686 of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.9327 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.5469 and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.4021 of the shares totaling 69.85 million with a market value of $23.35 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
Still, SEC filings show that on Mar 25 ’25, Che Austin (Officer) Proposed Sale 99 shares at an average price of $7.75 for $767.0. The insider now directly holds shares of Ginkgo Bioworks Holdings Inc (DNA).
